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In the UK, high profile campaigns to promote the early detection of
melanoma in the general public (MacKie and Hole, 1992; Melia,
1995) led to increased detection of thin melanomas. However, the
effects of the campaigns on mortality have been inconclusive, and
have generated a large workload. Given the low prevalence of
melanoma in the UK, targeted screening of those with a high risk of
melanoma may be a cost-effective strategy (Elwood, 1994; Little et
al, 1995; Tornberg et al, 1996; Jackson et al, 1998). The feasibility
of identifying a high-risk group has been investigated in two studies
conducted in the UK. Little et al (1995), reporting on families regis-
tered with an affluent general practice in Wessex, found that the
public’s self-assessment of mole counts was poor except for moles
on the front of the trunk which is not necessarily the site associated
with a high risk of melanoma (Farinas-Alvarez et al, 1999). Jackson
et al (1998) reported a good reliability for assessing risk factors, but
this study was based on attenders to general practice in Cheshire
who volunteered to attend for screening (388 out of 3105 patients).
In this paper, results are reported from the first population-based
screening study of a random sample of 1766 adults aged 25–69
years by a consultant dermatologist. The main aim was to investi-
gate the feasibility of screening in a broader mix of social class
groups than the previous studies (Little et al, 1995; Jackson et al,
1998). Results are reported on the accuracy with which people
assessed their risk factors of melanoma, the prevalence of risk
factors, the findings of a total skin examination, and anxiety
associated with the study. Data on attitudes towards screening are
reported in a separate paper (Eiser et al, submitted for publication).
MATERIALS AND METHODS
The intervention consisted of a postal questionnaire survey asking
questions about risk factors for melanoma and attitudes towards
screening. A letter from the general practitioner (GP) and derma-
tologist was enclosed which offered an appointment for screening
for skin cancer by a consultant dermatologist (CH) at the local
district hospital. Ethical approval was obtained from the Merton,
Sutton and Wandsworth Health Authority.
The study population came from one general practice in
Carshalton, Surrey with a population of 8000. A random sample of
households with people aged 25–69 years were stratified by the
social deprivation score of wards (Carstairs and Morris, 1992)
within the practice catchment area. The sample size was adequate
to study a prevalence of 10% (95% confidence intervals of ±
2.5%) for risk factors, and a sensitivity of 75% ± 10% to identify
by self-assessment a population at high risk of melanoma.
Data collection took 1 year from November 1997. Up to three
mailings of the questionnaire and letter were sent. Non-attenders
to the screening clinic were asked about the reasons for non-atten-
dance. The questionnaire asked about information on risk factors
for melanoma (Appendix) (MacKie, 1989), demographic details
and concerns about the invitation for screening. The question on
skin type asked about six groups: White skin which never tans and
always burns (I), White skin which burns at first and tans with
difficulty (II), White skin which tans easily and burns rarely (III),
White or olive skin which never burns and always tans (IV),
Brown skin (V), Black skin (VI) (MacKie, 1989).
Data on atypical moles and a history of sunburn, both risk
factors for melanoma (Bataille et al, 1998), were not collected
because of uncertainties about accuracy of reporting by the general
public (Little et al, 1995). A skin check guide described the type of
moles to be counted, and how to assess freckling.
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but can be black or light brown. It appears before the age of 35
years and does not appear to change colour in the sun. Moles can
be flat (not raised above the skin surface) or raised (felt above the
skin surface)’. Only moles ³ 2mm or more in diameter were
counted. A freckle was defined as ‘a light brown mark with an
irregular edge that appears or goes darker in the sun, and is usually
less than 2 mm in diameter.’
Moles and freckling were illustrated in photographs and
diagrams. People were asked about their knowledge of the early
signs of melanoma based on a recommended checklist (MacKie,
1990). Demographic details included date of birth, sex, age when
left full-time education and living with a partner or spouse.
Participants were asked whether they were pleased or concerned to
receive the questionnaire, and to be invited to the screening clinic.
At the clinic, held 1 day per week from 14:30 to 18:30 h, the
dermatologist asked about skin type, natural hair colour, a personal
history of skin cancer and a family history of melanoma. A whole
body examination was conducted excluding areas covered by
underwear. Data on moles and freckling were collected using the
same definitions as for the questionnaire. Anyone with a possible
skin cancer was asked to see their GP so that they could be referred
formally for excision/biopsy.
Descriptive statistics were used to study the uptake rate, and
prevalence of risk factors in relation to various demographic
factors in STATA. The accuracy with which people self-report risk
factors for melanoma was assessed using measures of sensitivity
(the proportion of people reporting a risk factor out of all those
reported to have the risk factor by the dermatologist), specificity
(the proportion of people who do not report a risk factor out of all
those reported not to have the risk factor by the dermatologist),
and Kappa statistics (the level of agreement between the indi-
vidual and dermatologist taking into account agreement occurring
by chance). The values of Kappa range from 0 (no agreement) to 1
(total agreement) and within this range, values < 0.4 are consid-
ered to represent poor agreement, 0.4–0.74 fair to good agreement
and ³ 0.75 excellent agreement (Landis and Koch, 1997). Logistic
regression was used to study the relation of demographic factors to
uptake rates, and to agreement of self-assessed risk factors to the
dermatologist’s observations.
Knowledge of the early signs of melanoma was studied in a
multiple choice question containing nine possible correct state-
ments interspersed with three incorrect statements. A score of
correct answers ranging from 0 to 12 was created by scoring 1 for
each of the nine correct signs that were ticked and scoring 1 for
each of the three incorrect signs that were not ticked.
RESULTS
A total of 1766 people were randomly selected from the GP list.
Of these, 164 were found to have moved or left the practice, and
two had died. Out of 1600, 1277 (77%) returned the questionnaire
and, of these, 896 (56% of 1600) also attended the clinic.
Compared with those who had only returned the questionnaire
(Q+C–), and those who did neither (Q–C–), those who had both
returned the questionnaire and attended the clinic (Q+C+) had
higher proportions of women than men (P < 0.001), those aged 50
or more than younger adults (P < 0.001) and people from the least
deprived than more deprived areas (P < 0.001, Table 1). The most
frequent reasons for non-attendance to the clinic were being too
busy (47%), believing they had no risk of skin cancer (27%), and
inconvenience of clinic time (18%). Only 1.5% objected to study.
Thirty-eight people of Black or Brown ethnic group were excluded
from subsequent analyses.
Comparing Q+C+ with Q+C– in regression analyses, men were
more likely to attend the clinic if they were aged 50 or more (odds
ratio (OR) 1.04, 95% confidence interval (CI) 1.02–1.06), or had
skin type I or II (OR 1.71, 95% CI 1.26–2.32). Women were less
likely to attend if they came from deprived areas (OR 0.8, 95% CI
0.70–0.93).
Only 4% found the questionnaire distressing. The proportion of
people who were nervous about the thought of coming for a skin
check was low (Q+C+ 15% and Q+C– 17%), but it was twice as
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Table 1 Distribution (%) of demographic factors in responders and non-responders
Responders
Characteristics Non-responders Questionnaire Questionnaire Total Number Significance
and clinic
(Q–C–) (Q+C–) (Q+C+)
Sex
Males 28 21 51 100 751 P < 0.001
Females 19 20 61 100 845
Total 23 21 56 100 1596
Number 369 331 896
Age
<50 years 27 22 51 100 1019 P < 0.05
³50 years 16 19 65 100 577
Total 23 21 56 100 1596
Number 369 331 896
Carstairs
1st quintile (affluent) 16 15 69 100 282
2nd quintile 21 23 56 100 438
3rd quintile 24 16 60 100 404
4th quintile 23 27 50 100 209 P < 0.001
5th quintile (deprived) 33 25 42 100 263
Total 369 331 896 1596high in women than men (20% and 10% respectively, P < 0.001).
Twice as many in Q+C+ as in Q+C– wanted to find out more about
their personal risk of skin cancer (74% vs 35%, P < 0.001).
The levels of agreement between self-reports of risk factors and
those recorded by the dermatologist were poor to fair for skin type,
freckling and mole counts (Tables 2 and 3). The level of agreement
was highest for hair colour when the reporting of red hair was
compared with other hair colours as one group (Kappa 0.67)
(Table 2). Counting moles on the head and neck was more accurate
among those with none or few freckles (Kappa 0.32) compared
with those having moderate or many freckles (Kappa 0.17). The
prevalence of freckling, and level of agreement for this factor or
for mole counts did not vary with time of year.
There was a tendency for people to report the highest risk cate-
gory less frequently than the dermatologist. Overall, 4% self-
reported skin type I, 7% many freckles and 7% many moles. A high
sensitivity could be achieved, although at a loss to specificity, if the
self-reports of the two highest risk categories for each factor were
compared with the dermatologist’s assessment of the highest risk
category (Tables 2 and 3). For example, for skin type, sensitivity
increased from 24% to 96%, and specificity decreased from 100%
to 63%, by comparing those self-reporting skin types I and II with
those recorded as skin type I by the dermatologist. However, the
prevalence of this potential target group for screening was high
(48%).
In regression analyses restricted to those reported by the derma-
tologist to have skin type I (number in analysis 158), self-reports
was more likely to agree with this assessment for males than
females (OR 3.1, 95% CI 1.4–6.8) after allowing for the effects of
age, social deprivation, age left education and living with a partner.
For those with many freckles and those with many moles, the
agreement was unrelated to demographic factors.
Ninety-three per cent knew about ‘growing’, 41% ‘having
different colours’ and 35% ‘having a ragged outline’ as signs of
melanoma. Seventy-six per cent also knew about ‘changing
shape’. Poor discriminatory signs ‘bleeding, oozing or crusting’,
and ‘a change in sensation such as itching or pain’ were reported
by 74% and 69% respectively. Fifty-four per cent reported one or
more incorrect signs: scaly, hairy or raised above the skin surface
as signs of melanoma. In regression analyses to study the relation
between a score of correct answers (range 0–12) and demographic
factors, significantly lower scores were found in men compared
with women (regression coefficient –0.72, 95% CI –1.03 to –0.42)
and in those who had left education by 16 (regression coefficient
–0.22, 95% CI –0.37 to –0.07).
Eighteen people with a suspicion of skin cancer were advised to
see their GPs for biopsy under the normal pattern of care. Twelve
basal cell carcinomas and two melanomas were histologically
confirmed. Both melanomas were thin (Breslow thickness
< 0.76 mm) and were found on the backs of men aged more than
50 years.
DISCUSSION
Cost-effective screening requires a good uptake rate, a practical and
accurate method for identifying the target population, and
a choice of a target population that ensures a high yield of melanomas
with consideration of both economic and psychological costs.
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Table 2 Distribution (%) of phenotypic factors compared between questionnaire and clinic data
Questionnaire data Clinic data
Hair coloura Black/brown Blond Red Total no.
Black/brown 85 18 15 620
Blond 13 80 12 172
Red 2 2 73 46
Total 100 100 100
Number 700 97 41 838
Reporting red hair
Sensitivity Specificity Kappa 0.67
73% 98%
Skin type III, IV II I Total no.
III, IV 97.1 45.6 4.4 459
II 2.5 54.4 71.7 378
I 0.4 0.0 23.9 39
Total 100 100 100
Number 243 474 159 876
Reporting of skin type I Sensitivity 24% Specificity 100% Kappa 0.34
Self-report of skin types I or Sensitivity 96% Specificity 63% Kappa 0.36
II compared with clinic report
of skin type I
Freckles None/few Moderate Many Total no.
None/few 80.7 62.4 29.9 498
Moderate 18.4 35.5 52.7 307
Many 0.9 2.1 17.4 65
Total 100 100 100
Number 347 189 334 870
Reporting many freckles Sensitivity 17% Specificity 99% Kappa 0.19
Self-report of moderate or Sensitivity 70% Specificity 74% Kappa 0.13
many freckles compared with 70% 74%
clinic report of many freckles
a 32 people reporting grey/white hair were excluded as the dermatologist concentrated on recording their natural hair colour at age 20.This study has shown that overall a good response (77%) can be
achieved from a postal questionnaire but this varies according to
demographic factors. The uptake to a screening clinic was lower
(56%), but this could be improved by focusing on an older age
group, among whom the incidence of melanoma is higher, offering
a wider choice of clinic times and providing health education to
increase awareness about skin cancer, particularly in more
deprived areas (Eiser et al, submitted for publication). In this
paper, 54% of people reported incorrect signs for melanoma.
The response rates to the questionnaire and uptake of screening
were lower than that in a study conducted in an affluent general prac-
tice population in Wessex (84% and 89% respectively) (Little et al,
1995). The social mix, wider choice of appointment times, and use of
the GP surgery may account for the higher response in Wessex.
The accuracy with which risk factors for melanoma could be
identified by a postal questionnaire was disappointing, and was
lower than in Wessex or Cheshire. One of the most important risk
factors for melanoma is having a large number of naevi but there
was a general reluctance for people to put themselves in the
extreme group having a large number of moles. One option for
targeted screening might be to select people who report moderate
to high risk, to ensure that all high risk people are included in
an intervention. However, this would increase the proportion
of people falling into the target group (e.g. 4% and 42%
self-reporting skin types I and II respectively).
The postal questionnaire raised anxiety about skin cancer in
only a small proportion of cases (< 4%). Although about 15% of
people said that they were nervous about attending for a skin
check this did not seem to be related to attendance rates. It was not
feasible to study anxiety over a longer period. The long-term
psychological effects of screening would be important in future
research testing new strategies.
The detection rate of melanomas (113 per 100 000) was very
high compared with the incidence rate in 25- to 69-year-olds in
England and Wales (8.9 per 100 000). Another study offering
screening by a dermatologist in the workplace showed a similar
high detection rate (Curley et al, 1993). Self-selection bias and the
high detection expected in the prevalence round of screening may
explain this finding.
The options for improving the early detection of melanoma
include general population professional screening, targeted
screening of a high risk group, self-screening and skin awareness.
General population screening would not be cost-effective in the
UK because of the low incidence. Targeted screening by GPs has
been proposed (Little et al, 1995; Jackson et al, 1998) but this may
benefit only a small proportion of melanomas and has consider-
able implications for workload, and psychological and economic
costs (Keeley, 1995; Sinclair, 1998). Advice on skin awareness
could be provided to encourage regular self-skin checks through a
practice nurse (Ringborg et al, 1991). This advice should aim to
improve awareness of the early signs of melanoma, demonstrated
to be lacking in this survey. Recognition of melanoma by the
general public might be improved by using a chart with
photographs representing a range of benign, borderline and malig-
nant lesions. The effectiveness of this approach would need to be
evaluated in terms of self-referral rates to GPs, and sensitivity and
specificity of detecting melanomas.
The results of previous feasibility studies for targeted screening
of melanoma in the UK may have been too optimistic. Future
strategies to improve and maintain both a high level of early detec-
tion by the general public and accurate recognition of suspicious
lesions by GPs need to be evaluated in terms of workload,
psychological outcome and economic costs.
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Table 3 Prevalence, level of agreement (kappa), sensitivity and specificity comparing questionnaire and clinic data for mole counts comparing one category for
each variable against the rest
Variable Questionnaire Clinic Kappa Sensitivity Specificity
Moles on head and neck ³10
Prevalence 4% 6% 0.22 23% 97%
Total number 37/867 48/867
Moles on trunk ³10
Prevalence 27% 33% 0.35 50% 84%
Total number 237/870 288/870
Moles on arms and hands ³10
Prevalence 23% 43% 0.34 42% 91%
Total number 200/870 371/870
Moles on legs and feet ³10
Prevalence 16% 29% 0.40 42% 94%
Total number 143/869 250/869
Overall quantity of moles
Many
Prevalence 7% 19% 0.32 26% 98%
Total Number 60/869 168/869
Moderate/many in
questionnaire vs many in
clinic data
Prevalence 37% 19% –0.1 74% 72%
Total number 320/869 168/869REFERENCES
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APPENDIX
What type of skin do you have?
Black skin 1
Brown skin 2
White or olive skin which never burns and always tans (IV) 3
White skin which tans easily and burns rarely (III) 4
White skin which burns at first and tans with difficulty (II) 5
White skin which never tans and always burns (I) 6
If you have BLACK OR BROWN SKIN, you have a very low risk of skin cancer and you do not need to answer the questions on pages
1–5. However, it would be helpful if you could answer the questions on the last page of the questionnaire.
What is your natural hair colour?
Black/dark or light brown 1
Fair/blond 2
Red/ginger 3
Other 4
To what extent do you have freckles?
No freckles 1
Few freckles only on one or two parts of body 2
Moderate freckling 3
Many large freckles usually greater than 2 mm on face, forearm and upper back 4
How many moles, 2 mm diameter or greater, have you on your skin?
Head & neck None 1 2 3 4 5 6 7 8 9 10 or more
Trunk None 1 2 3 4 5 6 7 8 9 10 or more
Arms & hands None 1 2 3 4 5 6 7 8 9 10 or more
Legs & feet None 1 2 3 4 5 6 7 8 9 10 or more
Overall, how moley do you think you are?
0
Few moles 1
Moderate number of moles 2
Many moles 3
Have you had any relatives with melanoma? (usually a dark/black form of skin cancer)
Yes 1
No 2
Don’t know 3
If YES: which of your relatives had melanoma?
Mother or father 1
Blood-related aunt or uncle 2
Brother or sister 3
Son or daughter 4
Other relative 5
Have you had a melanoma previously?
Yes 1
No 2
Don’t know 3